About the journal
Translational Oncology is an open-access journal published by Elsevier in Netherlands, publishing in english. It is listed in DOAJ and PUBMED according to the sources read. Declared publication charge: 3,880 USD. Declared review time at DOAJ: 22 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Elsevier
- ISSN
- 1944-7124 · 1936-5233
- Country
- Netherlands
- Languages
- english
- Access
- Open access
- Declared publication charge
- 3,880 USD
- Articles in DOAJ
- 2820
- Declared review time
- 22 weeks
- Declared peer-review model
- peer_review
- Official website
- https://www.sciencedirect.com/journal/translational-oncology
Index listings
- DOAJ · 2015-02-09
- PUBMED · 2009-08-18
- Indexing
- DOAJ · PUBMED
- APC
- 3,880 USD
- Declared review time (DOAJ)
- 22 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
2820
Most recent article
last month
Average review time (journal-declared via DOAJ)
22weeks
Works in OpenAlex
3197
Last recorded publication year
2026
h-index
95
i10-index
1697
From OpenAlex open data (CC0).
Editorial & policy12
- Last DOAJ review date
- 2026-04-27
- Added to DOAJ
- 2015-02-09
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPMCPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 98%
- ORCID iDs in current deposits
- 68%
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101472619
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Ferroptosis and cancer prognosis
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Ferroptosis and cancer prognosis
- Cancer Cells and Metastasis
- Cancer Cells and Metastasis
- Cancer, Hypoxia, and Metabolism
- Cancer, Hypoxia, and Metabolism
Show all subjects (50)
- Cancer-related molecular mechanisms research
- Cancer-related molecular mechanisms research
- RNA modifications and cancer
- RNA modifications and cancer
- MicroRNA in disease regulation
- MicroRNA in disease regulation
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Immune cells in cancer
- Immunotherapy and Immune Responses
- Immunotherapy and Immune Responses
- Pancreatic and Hepatic Oncology Research
- Lung Cancer Treatments and Mutations
- Lung Cancer Treatments and Mutations
- Immune cells in cancer
- Pancreatic and Hepatic Oncology Research
- Radiomics and Machine Learning in Medical Imaging
- Epigenetics and DNA Methylation
- Epigenetics and DNA Methylation
- Radiomics and Machine Learning in Medical Imaging
- Glioma Diagnosis and Treatment
- Glioma Diagnosis and Treatment
- Circular RNAs in diseases
- Single-cell and spatial transcriptomics
- Circular RNAs in diseases
- Immune Cell Function and Interaction
- Immune Cell Function and Interaction
- Cancer-related Molecular Pathways
- Cancer-related Molecular Pathways
- Cancer, Lipids, and Metabolism
- Cancer, Lipids, and Metabolism
- Single-cell and spatial transcriptomics
- Ubiquitin and proteasome pathways
- Lung Cancer Research Studies
- Ubiquitin and proteasome pathways
- Lung Cancer Research Studies
- CAR-T cell therapy research
- CAR-T cell therapy research
- Head and Neck Cancer Studies
- Head and Neck Cancer Studies
- MRI in cancer diagnosis
- Extracellular vesicles in disease
Keywords (DOAJ)
- translational cancer therapeutics
- precision oncology and biomarker development
- molecularly guided clinical trials
- mechanisms of therapeutic response and resistance
- experimental and early-phase onc
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ